{
  "success": true,
  "pagesUsed": [
    8,
    9,
    10,
    22,
    23,
    24,
    25,
    26
  ],
  "modelUsed": "gemini-3-flash-preview",
  "eligibility": {
    "eligibilityCriterionItems": [
      {
        "id": "eci_1",
        "name": "Informed Consent Understanding",
        "text": "Subject must be able to understand the nature of the study and have had the opportunity to have any questions answered by the investigator.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_2",
        "name": "Informed Consent Signature",
        "text": "Subject, if judged by the investigator to have decision making capacity, must voluntarily sign and date an informed consent form approved by an independent ethics committee (IEC)/institutional review board (IRB), prior to initiation of any study-specific procedures.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_3",
        "name": "Age Requirement",
        "text": "Subject must be an adult male or female, 30 years of age, or older.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_4",
        "name": "Compliance",
        "text": "Subject is willing and able to comply with procedures required in this protocol.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_5",
        "name": "Vitamin B12 Levels",
        "text": "Subject does not have a low vitamin B12 level (< 200 pg/mL); or does not have low-normal vitamin B12 level (< 300 pg/mL) with elevated methylmalonic acid (MMA > 0.41 µmol/L) at Screening Visit 1 (V1).",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_6",
        "name": "Cognitive Function",
        "text": "Subject has normal cognitive function (Mini-Mental State Examination [MMSE] score of 24 or greater). Subjects with mild cognitive impairment (MMSE score of 19 – 23 inclusive) may be enrolled if in the investigator's opinion, are able to adhere to all study requirements. Subjects with moderate or severe impairment (MMSE scores of 18 or below) may not be enrolled.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_7",
        "name": "Investigator Suitability",
        "text": "Subject is not considered by the investigator to be an unsuitable candidate to receive ABBV-951 for any reason.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_8",
        "name": "Parkinson's Diagnosis",
        "text": "Subject must have a diagnosis of levodopa-responsive idiopathic PD.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_9",
        "name": "Disease Activity and Medication",
        "text": "Subject must meet the following disease activity criteria: Must be taking a regimen of oral medications for PD that has remained unchanged for at least 30 days before commencing ABBV-951; this regimen must include levodopa-containing formulations such as CD/LD IR, CD/LD-CR, CD/LD extended release, CD/LD/entacapone. Must have a recognizable/identifiable \"Off\" and \"On\" state (motor fluctuations) as established through investigator observation and confirmed by PD diary entries recorded during the concordance test performed during the Screening Period.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_10",
        "name": "Off Time Requirement",
        "text": "Must be judged to be inadequately controlled by current therapy in the opinion of the investigator and experience a minimum of 2.5 hours of \"Off\" time per day as assessed by PD Diary prior to Day 1 (V3). Subjects who have received DBS therapy are eligible for the study, provided they are considered stable, are still levodopa responsive, and meet all other eligibility criteria.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_11",
        "name": "Skin Conditions Exclusion",
        "text": "Subject does not have a history of significant skin conditions or disorders (e.g., psoriasis, atopic dermatitis) or evidence of recent sunburn, acne, scar tissue, tattoo, open wound, branding, or colorations that in the investigator's opinion would interfere with the infusion of study drug or could interfere with study assessments.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_12",
        "name": "Substance Abuse Exclusion",
        "text": "Subject does not have a recent (within 6 months prior to study drug administration) history of drug or alcohol abuse that could preclude adherence to the protocol in the opinion of the investigator.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_13",
        "name": "Suicidal Ideation Exclusion",
        "text": "Subject does not have significant current suicidal ideation within 1 year prior to study drug administration as evidenced by answering \"yes\" to questions 4 or 5 on the suicidal ideation portion of the Columbia-Suicide Severity Rating Scale (C-SSRS) completed at either screening visit, or any history of suicide attempts within the last 2 years.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_14",
        "name": "Psychotic Episodes Exclusion",
        "text": "Subject does not have a history or presence of psychotic episodes that in the investigator's judgment are not adequately controlled by second generation (atypical) antipsychotics and that could preclude adherence to the protocol.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_15",
        "name": "Unstable Medical Conditions Exclusion",
        "text": "Subject does not have other clinically significant unstable medical conditions or any other reason that the investigator determines would interfere with the subject's participation in this study or would make the subject an unsuitable candidate to receive study drug.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_16",
        "name": "Allergic Reaction Exclusion",
        "text": "Subject does not have a history of allergic reaction or significant sensitivity to levodopa or constituents of the study drug (and its excipients) and/or other products in the same class.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_17",
        "name": "Levodopa Contraindications Exclusion",
        "text": "Subject does not have any known medical condition for which levodopa is contraindicated (e.g., suspicious undiagnosed melanoma, narrow-angle glaucoma, severe heart failure, severe cardiac arrhythmia, pheochromocytoma, untreated hyperthyroidism, or Cushing's syndrome and other circumstances where adrenergics are contraindicated).",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_18",
        "name": "Blood Donation Exclusion",
        "text": "Subject has not donated or lost 550 mL or more blood volume (including plasmapheresis) or received a transfusion of any blood product within 8 weeks prior to initial study drug administration.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_19",
        "name": "COVID-19 Exclusion",
        "text": "Subject has no known active COVID-19 infection. Subject must not have signs/symptoms associated with COVID-19 infection or known exposure to a confirmed case of COVID-19 infection during 14 days prior to Screening.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_20",
        "name": "Pregnancy Test Requirement",
        "text": "If female of childbearing potential, subject must have a negative serum pregnancy test at Screening Visit 1 (V1) and a negative urine pregnancy test on Day 1 (V3) prior to the start of the infusion of study drug.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_21",
        "name": "Female Contraception",
        "text": "If female, subject must be either postmenopausal, OR permanently surgically sterile OR for women of childbearing potential (WOCBP) practicing at least 1 protocol-specified method of birth control, that is effective from Day 1 (V3) through at least 30 days after the end of the infusion (end of Treatment Period).",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_22",
        "name": "Male Contraception",
        "text": "If male and sexually active with female partner(s) of childbearing potential, subject must agree, from Day 1 (V3) through 30 days after the end of the infusion of study drug, to practice protocol-specified contraception.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_23",
        "name": "Pregnancy/Breastfeeding Exclusion",
        "text": "If female, subject is not pregnant, breastfeeding, or considering becoming pregnant or donating eggs during the study or within 30 days after the end of the infusion of study drug.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_24",
        "name": "Male Procreation Exclusion",
        "text": "If male, subject is not considering fathering a child or donating sperm during the study or within 30 days after the end of the infusion of study drug (end of Treatment Period).",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_25",
        "name": "Investigational Product Exclusion",
        "text": "Subject has not received an investigational product other than ABBV-951 within a time period equal to 5 half-lives, if known, or within 6 weeks, whichever is longer, prior to study drug administration.",
        "instanceType": "EligibilityCriterionItem"
      }
    ],
    "eligibilityCriteria": [
      {
        "id": "ec_1",
        "identifier": "1",
        "category": {
          "code": "Inclusion",
          "codeSystem": "USDM",
          "decode": "Inclusion"
        },
        "criterionItemId": "eci_1",
        "instanceType": "EligibilityCriterion",
        "name": "Informed Consent Understanding",
        "nextId": "ec_2"
      },
      {
        "id": "ec_2",
        "identifier": "2",
        "category": {
          "code": "Inclusion",
          "codeSystem": "USDM",
          "decode": "Inclusion"
        },
        "criterionItemId": "eci_2",
        "instanceType": "EligibilityCriterion",
        "name": "Informed Consent Signature",
        "previousId": "ec_1",
        "nextId": "ec_3"
      },
      {
        "id": "ec_3",
        "identifier": "3",
        "category": {
          "code": "Inclusion",
          "codeSystem": "USDM",
          "decode": "Inclusion"
        },
        "criterionItemId": "eci_3",
        "instanceType": "EligibilityCriterion",
        "name": "Age Requirement",
        "previousId": "ec_2",
        "nextId": "ec_4"
      },
      {
        "id": "ec_4",
        "identifier": "4",
        "category": {
          "code": "Inclusion",
          "codeSystem": "USDM",
          "decode": "Inclusion"
        },
        "criterionItemId": "eci_4",
        "instanceType": "EligibilityCriterion",
        "name": "Compliance",
        "previousId": "ec_3",
        "nextId": "ec_5"
      },
      {
        "id": "ec_5",
        "identifier": "5",
        "category": {
          "code": "Inclusion",
          "codeSystem": "USDM",
          "decode": "Inclusion"
        },
        "criterionItemId": "eci_5",
        "instanceType": "EligibilityCriterion",
        "name": "Vitamin B12 Levels",
        "previousId": "ec_4",
        "nextId": "ec_6"
      },
      {
        "id": "ec_6",
        "identifier": "6",
        "category": {
          "code": "Inclusion",
          "codeSystem": "USDM",
          "decode": "Inclusion"
        },
        "criterionItemId": "eci_6",
        "instanceType": "EligibilityCriterion",
        "name": "Cognitive Function",
        "previousId": "ec_5",
        "nextId": "ec_7"
      },
      {
        "id": "ec_7",
        "identifier": "7",
        "category": {
          "code": "Inclusion",
          "codeSystem": "USDM",
          "decode": "Inclusion"
        },
        "criterionItemId": "eci_7",
        "instanceType": "EligibilityCriterion",
        "name": "Investigator Suitability",
        "previousId": "ec_6",
        "nextId": "ec_8"
      },
      {
        "id": "ec_8",
        "identifier": "8",
        "category": {
          "code": "Inclusion",
          "codeSystem": "USDM",
          "decode": "Inclusion"
        },
        "criterionItemId": "eci_8",
        "instanceType": "EligibilityCriterion",
        "name": "Parkinson's Diagnosis",
        "previousId": "ec_7",
        "nextId": "ec_9"
      },
      {
        "id": "ec_9",
        "identifier": "9",
        "category": {
          "code": "Inclusion",
          "codeSystem": "USDM",
          "decode": "Inclusion"
        },
        "criterionItemId": "eci_9",
        "instanceType": "EligibilityCriterion",
        "name": "Disease Activity and Medication",
        "previousId": "ec_8",
        "nextId": "ec_10"
      },
      {
        "id": "ec_10",
        "identifier": "10",
        "category": {
          "code": "Inclusion",
          "codeSystem": "USDM",
          "decode": "Inclusion"
        },
        "criterionItemId": "eci_10",
        "instanceType": "EligibilityCriterion",
        "name": "Off Time Requirement",
        "previousId": "ec_9",
        "nextId": "ec_20"
      },
      {
        "id": "ec_11",
        "identifier": "11",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_11",
        "instanceType": "EligibilityCriterion",
        "name": "Skin Conditions Exclusion",
        "nextId": "ec_12"
      },
      {
        "id": "ec_12",
        "identifier": "12",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_12",
        "instanceType": "EligibilityCriterion",
        "name": "Substance Abuse Exclusion",
        "previousId": "ec_11",
        "nextId": "ec_13"
      },
      {
        "id": "ec_13",
        "identifier": "13",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_13",
        "instanceType": "EligibilityCriterion",
        "name": "Suicidal Ideation Exclusion",
        "previousId": "ec_12",
        "nextId": "ec_14"
      },
      {
        "id": "ec_14",
        "identifier": "14",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_14",
        "instanceType": "EligibilityCriterion",
        "name": "Psychotic Episodes Exclusion",
        "previousId": "ec_13",
        "nextId": "ec_15"
      },
      {
        "id": "ec_15",
        "identifier": "15",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_15",
        "instanceType": "EligibilityCriterion",
        "name": "Unstable Medical Conditions Exclusion",
        "previousId": "ec_14",
        "nextId": "ec_16"
      },
      {
        "id": "ec_16",
        "identifier": "16",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_16",
        "instanceType": "EligibilityCriterion",
        "name": "Allergic Reaction Exclusion",
        "previousId": "ec_15",
        "nextId": "ec_17"
      },
      {
        "id": "ec_17",
        "identifier": "17",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_17",
        "instanceType": "EligibilityCriterion",
        "name": "Levodopa Contraindications Exclusion",
        "previousId": "ec_16",
        "nextId": "ec_18"
      },
      {
        "id": "ec_18",
        "identifier": "18",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_18",
        "instanceType": "EligibilityCriterion",
        "name": "Blood Donation Exclusion",
        "previousId": "ec_17",
        "nextId": "ec_19"
      },
      {
        "id": "ec_19",
        "identifier": "19",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_19",
        "instanceType": "EligibilityCriterion",
        "name": "COVID-19 Exclusion",
        "previousId": "ec_18",
        "nextId": "ec_23"
      },
      {
        "id": "ec_20",
        "identifier": "20",
        "category": {
          "code": "Inclusion",
          "codeSystem": "USDM",
          "decode": "Inclusion"
        },
        "criterionItemId": "eci_20",
        "instanceType": "EligibilityCriterion",
        "name": "Pregnancy Test Requirement",
        "previousId": "ec_10",
        "nextId": "ec_21"
      },
      {
        "id": "ec_21",
        "identifier": "21",
        "category": {
          "code": "Inclusion",
          "codeSystem": "USDM",
          "decode": "Inclusion"
        },
        "criterionItemId": "eci_21",
        "instanceType": "EligibilityCriterion",
        "name": "Female Contraception",
        "previousId": "ec_20",
        "nextId": "ec_22"
      },
      {
        "id": "ec_22",
        "identifier": "22",
        "category": {
          "code": "Inclusion",
          "codeSystem": "USDM",
          "decode": "Inclusion"
        },
        "criterionItemId": "eci_22",
        "instanceType": "EligibilityCriterion",
        "name": "Male Contraception",
        "previousId": "ec_21"
      },
      {
        "id": "ec_23",
        "identifier": "23",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_23",
        "instanceType": "EligibilityCriterion",
        "name": "Pregnancy/Breastfeeding Exclusion",
        "previousId": "ec_19",
        "nextId": "ec_24"
      },
      {
        "id": "ec_24",
        "identifier": "24",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_24",
        "instanceType": "EligibilityCriterion",
        "name": "Male Procreation Exclusion",
        "previousId": "ec_23",
        "nextId": "ec_25"
      },
      {
        "id": "ec_25",
        "identifier": "25",
        "category": {
          "code": "Exclusion",
          "codeSystem": "USDM",
          "decode": "Exclusion"
        },
        "criterionItemId": "eci_25",
        "instanceType": "EligibilityCriterion",
        "name": "Investigational Product Exclusion",
        "previousId": "ec_24"
      }
    ],
    "summary": {
      "inclusionCount": 13,
      "exclusionCount": 12,
      "totalCount": 25
    },
    "population": {
      "id": "pop_1",
      "name": "Study Population",
      "includesHealthySubjects": false,
      "criterionIds": [
        "ec_1",
        "ec_2",
        "ec_3",
        "ec_4",
        "ec_5",
        "ec_6",
        "ec_7",
        "ec_8",
        "ec_9",
        "ec_10",
        "ec_11",
        "ec_12",
        "ec_13",
        "ec_14",
        "ec_15",
        "ec_16",
        "ec_17",
        "ec_18",
        "ec_19",
        "ec_20",
        "ec_21",
        "ec_22",
        "ec_23",
        "ec_24",
        "ec_25"
      ],
      "instanceType": "StudyDesignPopulation",
      "description": "Target population defined by eligibility criteria"
    }
  },
  "rawResponse": {
    "eligibilityCriteria": [
      {
        "id": "ec_1",
        "name": "Informed Consent Understanding",
        "identifier": "1",
        "category": {
          "code": "Inclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Inclusion Criterion"
        },
        "criterionItemId": "eci_1",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_2",
        "name": "Informed Consent Signature",
        "identifier": "2",
        "category": {
          "code": "Inclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Inclusion Criterion"
        },
        "criterionItemId": "eci_2",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_3",
        "name": "Age Requirement",
        "identifier": "3",
        "category": {
          "code": "Inclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Inclusion Criterion"
        },
        "criterionItemId": "eci_3",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_4",
        "name": "Compliance",
        "identifier": "4",
        "category": {
          "code": "Inclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Inclusion Criterion"
        },
        "criterionItemId": "eci_4",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_5",
        "name": "Vitamin B12 Levels",
        "identifier": "5",
        "category": {
          "code": "Inclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Inclusion Criterion"
        },
        "criterionItemId": "eci_5",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_6",
        "name": "Cognitive Function",
        "identifier": "6",
        "category": {
          "code": "Inclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Inclusion Criterion"
        },
        "criterionItemId": "eci_6",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_7",
        "name": "Investigator Suitability",
        "identifier": "7",
        "category": {
          "code": "Inclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Inclusion Criterion"
        },
        "criterionItemId": "eci_7",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_8",
        "name": "Parkinson's Diagnosis",
        "identifier": "8",
        "category": {
          "code": "Inclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Inclusion Criterion"
        },
        "criterionItemId": "eci_8",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_9",
        "name": "Disease Activity and Medication",
        "identifier": "9",
        "category": {
          "code": "Inclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Inclusion Criterion"
        },
        "criterionItemId": "eci_9",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_10",
        "name": "Off Time Requirement",
        "identifier": "10",
        "category": {
          "code": "Inclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Inclusion Criterion"
        },
        "criterionItemId": "eci_10",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_11",
        "name": "Skin Conditions Exclusion",
        "identifier": "11",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_11",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_12",
        "name": "Substance Abuse Exclusion",
        "identifier": "12",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_12",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_13",
        "name": "Suicidal Ideation Exclusion",
        "identifier": "13",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_13",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_14",
        "name": "Psychotic Episodes Exclusion",
        "identifier": "14",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_14",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_15",
        "name": "Unstable Medical Conditions Exclusion",
        "identifier": "15",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_15",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_16",
        "name": "Allergic Reaction Exclusion",
        "identifier": "16",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_16",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_17",
        "name": "Levodopa Contraindications Exclusion",
        "identifier": "17",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_17",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_18",
        "name": "Blood Donation Exclusion",
        "identifier": "18",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_18",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_19",
        "name": "COVID-19 Exclusion",
        "identifier": "19",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_19",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_20",
        "name": "Pregnancy Test Requirement",
        "identifier": "20",
        "category": {
          "code": "Inclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Inclusion Criterion"
        },
        "criterionItemId": "eci_20",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_21",
        "name": "Female Contraception",
        "identifier": "21",
        "category": {
          "code": "Inclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Inclusion Criterion"
        },
        "criterionItemId": "eci_21",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_22",
        "name": "Male Contraception",
        "identifier": "22",
        "category": {
          "code": "Inclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Inclusion Criterion"
        },
        "criterionItemId": "eci_22",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_23",
        "name": "Pregnancy/Breastfeeding Exclusion",
        "identifier": "23",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_23",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_24",
        "name": "Male Procreation Exclusion",
        "identifier": "24",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_24",
        "instanceType": "EligibilityCriterion"
      },
      {
        "id": "ec_25",
        "name": "Investigational Product Exclusion",
        "identifier": "25",
        "category": {
          "code": "Exclusion",
          "codeSystem": "http://www.cdisc.org/USDM/criterionCategory",
          "decode": "Exclusion Criterion"
        },
        "criterionItemId": "eci_25",
        "instanceType": "EligibilityCriterion"
      }
    ],
    "eligibilityCriterionItems": [
      {
        "id": "eci_1",
        "name": "Informed Consent Understanding",
        "text": "Subject must be able to understand the nature of the study and have had the opportunity to have any questions answered by the investigator.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_2",
        "name": "Informed Consent Signature",
        "text": "Subject, if judged by the investigator to have decision making capacity, must voluntarily sign and date an informed consent form approved by an independent ethics committee (IEC)/institutional review board (IRB), prior to initiation of any study-specific procedures.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_3",
        "name": "Age Requirement",
        "text": "Subject must be an adult male or female, 30 years of age, or older.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_4",
        "name": "Compliance",
        "text": "Subject is willing and able to comply with procedures required in this protocol.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_5",
        "name": "Vitamin B12 Levels",
        "text": "Subject does not have a low vitamin B12 level (< 200 pg/mL); or does not have low-normal vitamin B12 level (< 300 pg/mL) with elevated methylmalonic acid (MMA > 0.41 µmol/L) at Screening Visit 1 (V1).",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_6",
        "name": "Cognitive Function",
        "text": "Subject has normal cognitive function (Mini-Mental State Examination [MMSE] score of 24 or greater). Subjects with mild cognitive impairment (MMSE score of 19 – 23 inclusive) may be enrolled if in the investigator's opinion, are able to adhere to all study requirements. Subjects with moderate or severe impairment (MMSE scores of 18 or below) may not be enrolled.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_7",
        "name": "Investigator Suitability",
        "text": "Subject is not considered by the investigator to be an unsuitable candidate to receive ABBV-951 for any reason.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_8",
        "name": "Parkinson's Diagnosis",
        "text": "Subject must have a diagnosis of levodopa-responsive idiopathic PD.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_9",
        "name": "Disease Activity and Medication",
        "text": "Subject must meet the following disease activity criteria: Must be taking a regimen of oral medications for PD that has remained unchanged for at least 30 days before commencing ABBV-951; this regimen must include levodopa-containing formulations such as CD/LD IR, CD/LD-CR, CD/LD extended release, CD/LD/entacapone. Must have a recognizable/identifiable \"Off\" and \"On\" state (motor fluctuations) as established through investigator observation and confirmed by PD diary entries recorded during the concordance test performed during the Screening Period.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_10",
        "name": "Off Time Requirement",
        "text": "Must be judged to be inadequately controlled by current therapy in the opinion of the investigator and experience a minimum of 2.5 hours of \"Off\" time per day as assessed by PD Diary prior to Day 1 (V3). Subjects who have received DBS therapy are eligible for the study, provided they are considered stable, are still levodopa responsive, and meet all other eligibility criteria.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_11",
        "name": "Skin Conditions Exclusion",
        "text": "Subject does not have a history of significant skin conditions or disorders (e.g., psoriasis, atopic dermatitis) or evidence of recent sunburn, acne, scar tissue, tattoo, open wound, branding, or colorations that in the investigator's opinion would interfere with the infusion of study drug or could interfere with study assessments.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_12",
        "name": "Substance Abuse Exclusion",
        "text": "Subject does not have a recent (within 6 months prior to study drug administration) history of drug or alcohol abuse that could preclude adherence to the protocol in the opinion of the investigator.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_13",
        "name": "Suicidal Ideation Exclusion",
        "text": "Subject does not have significant current suicidal ideation within 1 year prior to study drug administration as evidenced by answering \"yes\" to questions 4 or 5 on the suicidal ideation portion of the Columbia-Suicide Severity Rating Scale (C-SSRS) completed at either screening visit, or any history of suicide attempts within the last 2 years.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_14",
        "name": "Psychotic Episodes Exclusion",
        "text": "Subject does not have a history or presence of psychotic episodes that in the investigator's judgment are not adequately controlled by second generation (atypical) antipsychotics and that could preclude adherence to the protocol.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_15",
        "name": "Unstable Medical Conditions Exclusion",
        "text": "Subject does not have other clinically significant unstable medical conditions or any other reason that the investigator determines would interfere with the subject's participation in this study or would make the subject an unsuitable candidate to receive study drug.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_16",
        "name": "Allergic Reaction Exclusion",
        "text": "Subject does not have a history of allergic reaction or significant sensitivity to levodopa or constituents of the study drug (and its excipients) and/or other products in the same class.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_17",
        "name": "Levodopa Contraindications Exclusion",
        "text": "Subject does not have any known medical condition for which levodopa is contraindicated (e.g., suspicious undiagnosed melanoma, narrow-angle glaucoma, severe heart failure, severe cardiac arrhythmia, pheochromocytoma, untreated hyperthyroidism, or Cushing's syndrome and other circumstances where adrenergics are contraindicated).",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_18",
        "name": "Blood Donation Exclusion",
        "text": "Subject has not donated or lost 550 mL or more blood volume (including plasmapheresis) or received a transfusion of any blood product within 8 weeks prior to initial study drug administration.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_19",
        "name": "COVID-19 Exclusion",
        "text": "Subject has no known active COVID-19 infection. Subject must not have signs/symptoms associated with COVID-19 infection or known exposure to a confirmed case of COVID-19 infection during 14 days prior to Screening.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_20",
        "name": "Pregnancy Test Requirement",
        "text": "If female of childbearing potential, subject must have a negative serum pregnancy test at Screening Visit 1 (V1) and a negative urine pregnancy test on Day 1 (V3) prior to the start of the infusion of study drug.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_21",
        "name": "Female Contraception",
        "text": "If female, subject must be either postmenopausal, OR permanently surgically sterile OR for women of childbearing potential (WOCBP) practicing at least 1 protocol-specified method of birth control, that is effective from Day 1 (V3) through at least 30 days after the end of the infusion (end of Treatment Period).",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_22",
        "name": "Male Contraception",
        "text": "If male and sexually active with female partner(s) of childbearing potential, subject must agree, from Day 1 (V3) through 30 days after the end of the infusion of study drug, to practice protocol-specified contraception.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_23",
        "name": "Pregnancy/Breastfeeding Exclusion",
        "text": "If female, subject is not pregnant, breastfeeding, or considering becoming pregnant or donating eggs during the study or within 30 days after the end of the infusion of study drug.",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_24",
        "name": "Male Procreation Exclusion",
        "text": "If male, subject is not considering fathering a child or donating sperm during the study or within 30 days after the end of the infusion of study drug (end of Treatment Period).",
        "instanceType": "EligibilityCriterionItem"
      },
      {
        "id": "eci_25",
        "name": "Investigational Product Exclusion",
        "text": "Subject has not received an investigational product other than ABBV-951 within a time period equal to 5 half-lives, if known, or within 6 weeks, whichever is longer, prior to study drug administration.",
        "instanceType": "EligibilityCriterionItem"
      }
    ],
    "population": {
      "id": "pop_1",
      "name": "Study Population",
      "includesHealthySubjects": false,
      "plannedEnrollmentNumber": {
        "maxValue": 240,
        "instanceType": "Range"
      },
      "plannedMinimumAge": "P30Y",
      "plannedSex": [
        {
          "code": "Male",
          "codeSystem": "http://www.cdisc.org/USDM/sex",
          "decode": "Male"
        },
        {
          "code": "Female",
          "codeSystem": "http://www.cdisc.org/USDM/sex",
          "decode": "Female"
        }
      ],
      "criterionIds": [
        "ec_1",
        "ec_2",
        "ec_3",
        "ec_4",
        "ec_5",
        "ec_6",
        "ec_7",
        "ec_8",
        "ec_9",
        "ec_10",
        "ec_11",
        "ec_12",
        "ec_13",
        "ec_14",
        "ec_15",
        "ec_16",
        "ec_17",
        "ec_18",
        "ec_19",
        "ec_20",
        "ec_21",
        "ec_22",
        "ec_23",
        "ec_24",
        "ec_25"
      ],
      "instanceType": "StudyDesignPopulation"
    }
  }
}